"uuid:ID","name","id","description","text","instanceType","label"
"724a90ef-756d-46b6-b5bd-44ef6a0d7e1f","OBJ1","Objective_1","Main objective","To determine if there is a statistically significant relationship (overall Type 1 erroralpha=0.05) between the change in both the ADAS-Cog (11) and CIBIC+ scores, and drug dose (0, 50 cm2 [54 mg], and 75 cm2 [81 mg]).","Objective",""
"b9cd59e5-dd54-4d0e-9e5e-38b78f0c59c1","OBJ2","Objective_2","Safety","To document the safety profile of the xanomeline TTS.","Objective",""
"d31671c7-d85a-4361-9d93-6956fe548704","OBJ3","Objective_3","Behaviour","To assess the dose-dependent improvement in behavior. Improved scores on the Revised Neuropsychiatric Inventory (NPI-X) will indicate improvement in these
areas.","Objective",""
